Axogen Q2 2024 Adj. EPS $0.05 Beats $(0.04) Estimate, Sales $47.912M Beat $43.391M Estimate
Portfolio Pulse from Benzinga Newsdesk
Axogen reported Q2 2024 adjusted EPS of $0.05, beating the estimate of $(0.04). Sales were $47.912 million, surpassing the $43.391 million estimate.
August 08, 2024 | 11:01 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Axogen's Q2 2024 adjusted EPS of $0.05 beat the estimate of $(0.04), and sales of $47.912 million exceeded the $43.391 million estimate.
Axogen's better-than-expected earnings and sales figures are likely to positively impact its stock price in the short term. Beating both EPS and sales estimates typically boosts investor confidence and can lead to a stock price increase.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100